• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Conference outputs
    • View Item
    • Home
    • Griffith Research Online
    • Conference outputs
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Tenofovir indcued reversible nephrogenic diabetes insipidus without fanconi syndrome in a patient with hepatitis b

    Author(s)
    Thet, Z
    Malalasekera, S
    Al-Safffi, N
    Han, T
    Han, C
    Hein, Y
    Hasell, R
    Griffith University Author(s)
    Thet, Zaw
    Year published
    2018
    Metadata
    Show full item record
    Abstract
    Background In patients with Hepatitis B Virus, there are approximately 10 cases of Tenofovir related Fanconi Syndrome but no report of nephrogenic diabetes insipidus. Case Report A 54 year old female with hepatitis B virus on tenofovir for 1 year presented with polyuria and acute urinary retnetion. There was no history of diabetes, thyroid, kidney and intracranial pathology. The patient had acute transverse meyelitis that was treated successfully with steroid and plasmapharesis, however polyuria (10 L/day) persisted beyond an accepted time frame. As HBV‐PCR was negative, tenofovir was ceased. Her full blood count, inflammatory ...
    View more >
    Background In patients with Hepatitis B Virus, there are approximately 10 cases of Tenofovir related Fanconi Syndrome but no report of nephrogenic diabetes insipidus. Case Report A 54 year old female with hepatitis B virus on tenofovir for 1 year presented with polyuria and acute urinary retnetion. There was no history of diabetes, thyroid, kidney and intracranial pathology. The patient had acute transverse meyelitis that was treated successfully with steroid and plasmapharesis, however polyuria (10 L/day) persisted beyond an accepted time frame. As HBV‐PCR was negative, tenofovir was ceased. Her full blood count, inflammatory makers, blood sugar, thyroid, kidney and liver function tests were normal. Urine didn’t show haematuria or protienuria. Renal imaging showed no evidence of obstructive uropathy or chronic kidney disease. MRI brain excluded any intracranial lesions.Primary polydipsia was excluded as urine osmolality was not elevated >500 mosmol/kg during 8 h water deprivation and the patient responded to DDAVP significantly. Submaximal response to DDAVP at 30% excluded complete nephrogenic DI and complete central DI. Normal ADH result and resolution of polyuria after cessation of an offending drug suggested both complete and partial central DI was unlikely. A submaximal rise in urine osmolality (358 mmol/kg) with DDAVP producing elevation of urine osmolality of approximately 30% suggested a diagnosis of partial nephrogenic DI. Polyuria resolved 6 weeks after tenofvoir therapy alone was discontinued. Conclusion Patients receiving tenofovir must be monitored closely even several months after initiation of treatment as the drug can cause nephrogenic DI. Combinging plasma ADH assay with water deprivation testing can lead to greater accuracy in differentiating the different forms of DI.
    View less >
    Conference Title
    Nephrology
    Volume
    23
    Issue
    S3
    Publisher URI
    https://onlinelibrary.wiley.com/doi/10.1111/nep.13442
    Subject
    Clinical sciences
    Science & Technology
    Life Sciences & Biomedicine
    Urology & Nephrology
    Publication URI
    http://hdl.handle.net/10072/404483
    Collection
    • Conference outputs

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander